Nintedanib Treatment in Unicentric Castleman Disease
Clinical trial NCT06643091 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06643091
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-01
- Primary completion
- 2030-05-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.